| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/28/2004 | EP1412485A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/28/2004 | EP1412484A1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 04/28/2004 | EP1412483A1 Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications |
| 04/28/2004 | EP1412482A2 Uses of opg ligand to modulate immune responses |
| 04/28/2004 | EP1412481A2 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 04/28/2004 | EP1412480A1 Method for preventing the adhesion of particles |
| 04/28/2004 | EP1412479A2 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 04/28/2004 | EP1412387A2 Transporters and ion channels |
| 04/28/2004 | EP1412382A2 Interferon gamma polypeptide variants |
| 04/28/2004 | EP1412379A2 Antigenic polypeptides |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412372A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1411994A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 04/28/2004 | EP1411989A2 Methods for improving cell line activity in immunoisolation devices |
| 04/28/2004 | EP1411983A1 Bispecific antibodies that bind to vegf receptors |
| 04/28/2004 | EP1411980A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 04/28/2004 | EP1411957A1 Treatment of muscular distrophy with cord blood cells |
| 04/28/2004 | EP1411880A2 Recombinant vsv for the treatment of tumor cells |
| 04/28/2004 | EP1411770A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 04/28/2004 | EP1326628B1 Chemokine mutants in the treatment of multiple sclerosis |
| 04/28/2004 | EP1286684B1 use of cxcr4 antagonists for treating autoimmune diseases and cancer |
| 04/28/2004 | EP1272846A4 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/28/2004 | EP1104231A4 Biodegradable high oxidative stability oils |
| 04/28/2004 | EP1084232B1 Genetically-modified fibroblasts and the use thereof |
| 04/28/2004 | EP1073716B1 Improvements in or relating to separation processes |
| 04/28/2004 | EP1012190A4 Eosinophil eotaxin receptor |
| 04/28/2004 | EP0944723B1 Mammalian chemokines |
| 04/28/2004 | EP0939797A4 Defined systems for epithelial cell culture and use thereof |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0871414B1 Preparation methods of tissue for implantation |
| 04/28/2004 | EP0856054B1 Monoclonal antibody br110 and uses thereof |
| 04/28/2004 | EP0810888B1 Resorbable extracellular matrix for reconstruction of cartilage tissue |
| 04/28/2004 | EP0799317B1 Method for secreting thrombopoietin polypeptides |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | EP0698095B1 Bmp-10 compositions |
| 04/28/2004 | EP0555315B1 HUMAN CELL LINE STABLY EXPRESSING 5cDNAs ENCODING PROCARCINOGEN-ACTIVATING ENZYMES |
| 04/28/2004 | CN1492930A Anti-interferon-šŒantibodies |
| 04/28/2004 | CN1492927A Human FGF23 protein mutant lowering blood phosphorus level |
| 04/28/2004 | CN1492879A Protein tau |
| 04/28/2004 | CN1492047A Recmobined plasmid containing c-fos promotor and reporter gene and its producing method and use |
| 04/28/2004 | CN1492046A Genetic sequence of coded flavonoid path enzyme and its use |
| 04/28/2004 | CN1492040A Natural antibody of monoclonal human |
| 04/28/2004 | CN1491956A Gene for changing cotton fiber quantity and character and its encoding protein and use |
| 04/28/2004 | CN1491728A Tissue engineering blood vessel of gene modification |
| 04/28/2004 | CN1491624A Modified biological material |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/28/2004 | CA2447199A1 Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
| 04/28/2004 | CA2447190A1 Homing of donor cells to a target zone in tissue using active therapeutics or substances |
| 04/28/2004 | CA2447167A1 Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
| 04/27/2004 | US6727412 For resistance to diseases, insects, heat, drought; better crop maturity, yield, agronomic quality, uniformity, germination, stand establishment, growth rate, plant & ear height |
| 04/27/2004 | US6727409 Active against lepidoptera |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727350 Toso |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727222 Transcriptional regulator |
| 04/27/2004 | US6727094 Cultured cells of Rhaphiolepis umbellata Thunb. and a method for culturing tissues of the Rhaphiolepis umbellata Thunb. by using said cultured cells |
| 04/27/2004 | US6727093 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by cd8+ class i major histocompatibility complex restricted cytotoxic t-lymphocytes of patients harboring latent human cytomegalovirus infection |
| 04/27/2004 | US6727092 Methods for the simultaneous detection of HCV antigens and HCV antibodies |
| 04/27/2004 | US6727074 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 04/27/2004 | US6727058 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 04/27/2004 | US6726910 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/27/2004 | US6726907 Purified adenoviral compositions |
| 04/27/2004 | CA2295999C Nik proteins, nucleic acids and methods |
| 04/27/2004 | CA2152047C Production of human recombinant collagen in the milk of transgenic animals |
| 04/27/2004 | CA2058370C Monoclonal antibodies against human tumor necrosis factor .alpha. |
| 04/27/2004 | CA1341455C Process for transforming gramineae and the products thereof |
| 04/22/2004 | WO2004034013A2 Genotoxicity analysis |
| 04/22/2004 | WO2004033693A1 Methods vectors plasmids and methods for increasing expression of recombinant polypeptides |
| 04/22/2004 | WO2004033690A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | WO2004033674A1 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
| 04/22/2004 | WO2004033673A2 Production process for plant biomass and its use |
| 04/22/2004 | WO2004033672A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | WO2004033635A2 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| 04/22/2004 | WO2004033634A2 Transgenic cells transfected with pituitary tumor transforming gene (pttg) expression vectors and uses therefor |
| 04/22/2004 | WO2004033627A2 Methods for efficient production of mammalian recombinant proteins |
| 04/22/2004 | WO2004033625A2 Urocortin-deficient mice and uses thereof |
| 04/22/2004 | WO2004033622A2 Preservation of rna and morphology in cells and tissues |
| 04/22/2004 | WO2004033614A1 Molecule-releasing apparatus and molecule-releasing method |
| 04/22/2004 | WO2004033494A1 Tryptase polypeptide and uses thereof |
| 04/22/2004 | WO2004033396A2 Method for enriching adherent monocyte populations |
| 04/22/2004 | WO2004032951A1 Immunotherapy in cancer treatment |
| 04/22/2004 | WO2004032881A2 Implantation of encapsulated biological materials for treating diseases |
| 04/22/2004 | WO2004032850A2 Uses of human zven antagonists |
| 04/22/2004 | WO2004024928A3 Transformed plants with enhanced prenylquinone biosynthesis |
| 04/22/2004 | WO2004020639A3 Production of multimeric fusion proteins using a c4bp scaffold |
| 04/22/2004 | WO2004015395A3 Method for identifying mhc-presented peptide epitopes for t cells |
| 04/22/2004 | WO2004009237A3 Sperm cell process system |
| 04/22/2004 | WO2004007696A3 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 04/22/2004 | WO2004003178A3 Decellularized tissue |
| 04/22/2004 | WO2003103607A3 Viral envelope mediated fusion assay |
| 04/22/2004 | WO2003088812A3 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy |
| 04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
| 04/22/2004 | WO2003072014B1 Minicell compositions and methods |
| 04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
| 04/22/2004 | WO2003068937A3 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 04/22/2004 | WO2003060084A9 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |